## **Core Concept**
Bicalutamide is a medication used in the treatment of prostate cancer. It belongs to a class of drugs known as **nonsteroidal antiandrogens**. The core concept here involves understanding the role of androgens and their receptors in prostate cancer.

## **Why the Correct Answer is Right**
Bicalutamide works by specifically inhibiting the **androgen receptor**. Androgens, such as testosterone and dihydrotestosterone (DHT), play a crucial role in the growth and development of prostate cancer cells. By binding to the androgen receptor, bicalutamide prevents androgens from exerting their effects, thereby inhibiting the growth of prostate cancer cells. This mechanism is critical in the management of prostate cancer, especially in advanced stages.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because bicalutamide's primary mechanism is not related to inhibiting 5-alpha-reductase, an enzyme involved in converting testosterone to DHT. Drugs like finasteride inhibit this enzyme.
- **Option B:** This option is incorrect as bicalutamide does not primarily act by inhibiting the synthesis of androgens. That action is more characteristic of drugs like ketoconazole, which inhibits steroid synthesis.
- **Option C:** This option might seem related but is not the correct mechanism for bicalutamide. Bicalutamide's action is more specific to blocking the androgen receptor rather than broadly inhibiting steroid receptors.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that bicalutamide can cause **gynecomastia** and breast pain due to its antiandrogenic effects. This side effect is significant enough that prophylactic measures, such as tamoxifen, might be considered in some cases to mitigate this effect.

## **Correct Answer:** D. Androgen receptors.